We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

The AFA encourages family caregivers to use T.H.A.N.K.S. to create a dementia-friendly Thanksgiving celebration for their ...

What is reminiscence therapy? It's the approach Chris Hemsworth is using to fight his father's Alzheimer's disease in his new ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...

Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — ...

A new respite program for caregivers of Alzheimer's patients highlights the need for support for Vermont families battling ...